Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community-Reference-Cited by-同舟云学术

Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community

Published:2004-06 Issue:6 Volume:19 Page:676-683
ISSN:0884-8734
Container-title:Journal of General Internal Medicine
language:en
Short-container-title:J Gen Intern Med

Author:

Rochon Paula A.,Sykora Kathy,Bronskill Susan E.,Mamdani Muhammad,Anderson Geoffrey M.,Gurwitz Jerry H.,Gill Sudeep,Tu Jack V.,Laupacis Andreas

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://www.springerlink.com/index/pdf/10.1111/j.1525-1497.2004.30328.x

Reference31 articles.

1. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure); 2001. American College of Cardiology Website. Available at: http://www.acc.org/clinical/guidelines/failure/hf_index.htm. Accessed November 24, 2003.

2. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol. 1995;26:1376–98.

3. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293–302.

4. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429–34.

5. Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA. 1988;259:539–44.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin-Converting Enzyme Inhibitor Dose Optimization and Its Associated Factors at Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia;VASC HEALTH RISK MAN;2022

2. Management of acute coronary syndromes in older adults;European Heart Journal;2021-08-04

3. High-dose versus low-dose angiotensin converting enzyme inhibitors in heart failure: systematic review and meta-analysis;Open Heart;2020-08

4. Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients;Journal of Clinical Medicine;2020-01-03

5. Utilization and Dose Optimization of Angiotensin-Converting Enzyme Inhibitors among Heart Failure Patients in Southwest Ethiopia;BioMed Research International;2019-04-24